SlideShare ist ein Scribd-Unternehmen logo
1 von 15
UCSF Lean Launchpad For Life Science
and Healthcare Startups
Medical Device Track
Class 2
Customer Segments
October 8, 2013
Allan May
Chairman, Life Science Angels
amay@lifescienceangels.com
UCSF Lean Launchpad - Allan May ©
MEDICAL DEVICE MARKETS ARE OFTEN
- BUT NOT ALWAYS - MULTI-SIDED
MARKETS
 The patient is the beneficiary of the device or
service and must receive a clinical benefit
 The physician is the device user
 The hospital or physician practice is the
economic buyer
 Medicare or private insurance payor is the
ultimate influencer of what gets purchased
 The FDA determines what can be legally sold
 CMS determines what Medicare pays for

UCSF Lean Launchpad - Allan May ©
MEDICAL DEVICE CUSTOMER
SEGMENTS IN A NUTSHELL
 FOLLOW THE MONEY!!!
 Understand whether the device is reimbursed



Being covered in the hospital DRG is NOT
reimbursement, it is an expense
Unless you are replacing a device currently being used
within a DRG at a lesser cost

 Determine who the payor is
 Understand the funds flow process
 Understand who gets paid


Same physician, or shifting specialties (and so some
other physician will no longer get paid)

UCSF Lean Launchpad - Allan May ©
PHYSICIANS AS CUSTOMERS?
 Physicians often decide what device to use



Depends on where the physician works; how she is paid
Hospital-based physicians are influencers (at best)


The ability of physicians to influence hospital purchasing
decisions is evaporating





Novare vs. Intuitive Surgical
Same cost versus higher cost – Figure 8

Private practice physicians are purchasers

 Actually multiple physician specialties often influence the
course of therapy of a patient


EG, LCP Pacemaker - GP; cardiologist; interventional
cardiologist; electrophysiologist

 Physician turf battlers are common


E.g., cardiac surgeons versus interventional cardiologists

UCSF Lean Launchpad - Allan May ©
PATIENTS AS CUSTOMERS?



Competing trends are at work
Patients are far better informed and increasingly request
specific devices and procedures


Can impact where substantial data exists as to clinical outcomes
and benefits







Prostate or breast cancer therapy choices

But, the evidence requirement for new devices or procedures is
daunting

Physicians often recommend existing or standard devices and
procedures until the adverse effects of new technology (and
how to handle those effects) are well known
Out-of-pocket or self-pay usually dooms device business
models



Cosmetic versus therapeutic procedures
Check out impact of reimbursement and market size – InvisiAlign
http://provider.invisalign.com/Pages/pay.aspx

UCSF Lean Launchpad - Allan May ©
HOSPITALS AS CUSTOMERS?
 Hospital purchases are increasingly governed by
“New Technology Committees”, who’s purpose is
to keep new technologies out of hospitals
 Hospitals purchase devices that are reimbursed
 Hospitals will only purchase devices that claim to
lower costs where those cost benefits are proven
by hard data
 and often still require onsite trials to verify data
generated elsewhere

 Who is the Customer in the hospital?
 What exactly is the purchasing process, and who
all are involved in that process?
UCSF Lean Launchpad - Allan May ©
UNDERSTANDING CUSTOMERS REQUIRES
UNDERSTANDING REIMBURSEMENT
 Existing reimbursement code versus new code
versus not reimbursed
 Re-engineer your product or solution if possible to
still achieve Product Market Fit while falling under
an existing code


BTW, ditto for falling under 510k versus PMA (more later)

 Understand the length of time it takes to get a new
code and when you are able to effectively start
 Understand who owns the patient and the physician
referral process

UCSF Lean Launchpad - Allan May ©
INTERVIEWING PHYSICIANS
 You need to view one or more target procedures to be
effective in speaking with physicians
 Take a prototype or mockup to hand/show them


Animations and CAD CAM is good but not good enough

 Physicians are all difficult to interview effectively, but
surgeons tend to be harder than non surgeons
 Physicians are scientists and tend to answer exactly what is
asked, not interpret what you meant to ask
 Physicians often believe they are better than their peers
and so don’t experience the complications or adverse
events that others might


How do they perform the procedure? How would they do it better?
What changes would they like? Why

UCSF Lean Launchpad - Allan May ©
PHYSICIAN – PATIENT GAINS
 Same or better clinical outcomes in a less invasive
setting


Invasive → less invasive → non-invasive



Often involves a reduction in expense
Some procedures move out of hospital surgery to outpatient
and then back

 Opens up previously untreatable patients to therapy
 Increases procedure speed (reduces complexity or
time)


Count steps in the existing procedure versus yours

 No Harm, No Foul solutions
UCSF Lean Launchpad - Allan May ©
PHYSICIAN – PATIENT PAINS
 Reduces mortality
 Reduces morbidity


Complications, adverse events

 Increases durability of procedure



Balloon angioplasty → stents → Drug Eluting Stents
But re-occurrence can generate additional physician revenue

 Prevents losing patient to another specialty

UCSF Lean Launchpad - Allan May ©
MEDICAL DEVICE MARKET TYPES
For Physicians and Hospitals
 Existing



Better clinical outcomes; same physician
If moves procedure to new physician (cardiac surgeon to
interventional cardiologist), will provoke a turf war between
supporters and saboteurs


Carotid stenting

 Resegmented


Niche products aimed at specific patient populations have long
been successful

 New


If and when reimbursed, the solution is embraced

 Clone


Often done regarding procedures; rare in devices due to IP

UCSF Lean Launchpad - Allan May ©
MEDICAL DEVICE COMPANIES
AS ULTIMATE “CUSTOMERS”
 Almost all innovation in medical devices resulted in
acquisitions by major strategics


In-house R&D innovation is negligible

 Is it still possible to build a major standalone medical
device company?



Will there be another J&J, Medtronic, GE?
Manufacturing is local; marketing, sales and customer
support are global

 What pain or gain do you provide to the acquiror?


Why can’t they just do the same thing without you?

UCSF Lean Launchpad - Allan May ©
MEDICAL DEVICE MARKET TYPES
For Major Medical Device Companies


Existing



Better clinical outcomes; same physician
If moves procedure to new physician (cardiac surgeon to interventional
cardiologist), can fall outside of ability of major companies to leverage
existing sales and marketing infrastructure




Resegmented






This is a good place for startups
But major device companies are pretty good at this also
The key is to spot holes in their IP

New





Surgeons versus interventionalists

The Holy Grail for startups
Pioneering often requires startup to build its own sales and marketing
channel to enable the major company to enter the market

Clone


Probably not a place for startups to play

UCSF Lean Launchpad - Allan May ©
GAINS AND PAINS TO ACQUIRORS
 Leverage existing corporate resources and customer
call points
 Gain entry with new widget to sell rest of line
 Facilitate upselling

 Increase market size


Add to sales and profits



Don’t cannibalize existing markets
Eventually this will fail as reverse innovation becomes a
reality

 Create new markets
 Increase share relative to competitors
UCSF Lean Launchpad - Allan May ©
UCSF Lean Launchpad For Life Science
and Healthcare Startups
Medical Device Track
Class 2
Customer Segments
October 8, 2013

Allan May
Chairman, Life Science Angels
amay@lifescienceangels.com

UCSF Lean Launchpad - Allan May ©

Weitere ähnliche Inhalte

Was ist angesagt?

Innovation Process Management
Innovation Process ManagementInnovation Process Management
Innovation Process ManagementDr. Arturo Perez
 
Market Opportunity Navigator, Lesson 2: Market Opportunity Set
Market Opportunity Navigator, Lesson 2: Market Opportunity SetMarket Opportunity Navigator, Lesson 2: Market Opportunity Set
Market Opportunity Navigator, Lesson 2: Market Opportunity SetWhere to Play
 
Buy Build or Partner: Choosing the right inovation Strategy
Buy Build or Partner: Choosing the right inovation StrategyBuy Build or Partner: Choosing the right inovation Strategy
Buy Build or Partner: Choosing the right inovation StrategyEgress Solutions
 
Chap005 five genric strategies
Chap005  five genric strategiesChap005  five genric strategies
Chap005 five genric strategiesAjit Kumar
 
Eli Lilly Global Strategy
Eli Lilly Global StrategyEli Lilly Global Strategy
Eli Lilly Global Strategyguest90d5a
 
Novartis - Strategy Memo
Novartis - Strategy MemoNovartis - Strategy Memo
Novartis - Strategy MemoRheetam Mitra
 
Asset healthindex2014
Asset healthindex2014Asset healthindex2014
Asset healthindex2014matsoh
 
What is disruptive innovation?
What is disruptive innovation?What is disruptive innovation?
What is disruptive innovation?Nei Grando
 
Global Generic Pharmaceutical Market - Qualitative and Quantitative Analysis
Global Generic Pharmaceutical Market - Qualitative and Quantitative AnalysisGlobal Generic Pharmaceutical Market - Qualitative and Quantitative Analysis
Global Generic Pharmaceutical Market - Qualitative and Quantitative AnalysisAiswariya Chidambaram
 
Pfizer Strategic Analysis
Pfizer Strategic AnalysisPfizer Strategic Analysis
Pfizer Strategic AnalysisPharm Net
 
Case Shouldice Hospital - Blueprint
Case Shouldice Hospital - BlueprintCase Shouldice Hospital - Blueprint
Case Shouldice Hospital - BlueprintFernando Holanda
 
Business Model Canvas Research Report
Business Model Canvas Research ReportBusiness Model Canvas Research Report
Business Model Canvas Research ReportGhani Kolli
 
Yenileşim (İnovasyon) Hunisini Geliştirmek
Yenileşim (İnovasyon) Hunisini GeliştirmekYenileşim (İnovasyon) Hunisini Geliştirmek
Yenileşim (İnovasyon) Hunisini GeliştirmekNovida Global
 

Was ist angesagt? (20)

Innovation Process Management
Innovation Process ManagementInnovation Process Management
Innovation Process Management
 
Market Opportunity Navigator, Lesson 2: Market Opportunity Set
Market Opportunity Navigator, Lesson 2: Market Opportunity SetMarket Opportunity Navigator, Lesson 2: Market Opportunity Set
Market Opportunity Navigator, Lesson 2: Market Opportunity Set
 
The business side of healthcare
The business side of healthcareThe business side of healthcare
The business side of healthcare
 
Buy Build or Partner: Choosing the right inovation Strategy
Buy Build or Partner: Choosing the right inovation StrategyBuy Build or Partner: Choosing the right inovation Strategy
Buy Build or Partner: Choosing the right inovation Strategy
 
Chap005 five genric strategies
Chap005  five genric strategiesChap005  five genric strategies
Chap005 five genric strategies
 
Eli Lilly Global Strategy
Eli Lilly Global StrategyEli Lilly Global Strategy
Eli Lilly Global Strategy
 
Novartis - Strategy Memo
Novartis - Strategy MemoNovartis - Strategy Memo
Novartis - Strategy Memo
 
Asset healthindex2014
Asset healthindex2014Asset healthindex2014
Asset healthindex2014
 
Ent. Innovation
Ent. InnovationEnt. Innovation
Ent. Innovation
 
INNOVATIONS IN MARKETING
INNOVATIONS IN MARKETINGINNOVATIONS IN MARKETING
INNOVATIONS IN MARKETING
 
What is disruptive innovation?
What is disruptive innovation?What is disruptive innovation?
What is disruptive innovation?
 
Global Generic Pharmaceutical Market - Qualitative and Quantitative Analysis
Global Generic Pharmaceutical Market - Qualitative and Quantitative AnalysisGlobal Generic Pharmaceutical Market - Qualitative and Quantitative Analysis
Global Generic Pharmaceutical Market - Qualitative and Quantitative Analysis
 
Pfizer Strategic Analysis
Pfizer Strategic AnalysisPfizer Strategic Analysis
Pfizer Strategic Analysis
 
Team m patch aid v5 aug 31
Team m   patch aid v5 aug 31Team m   patch aid v5 aug 31
Team m patch aid v5 aug 31
 
Summary of Blue Ocean Strategy
Summary of Blue Ocean StrategySummary of Blue Ocean Strategy
Summary of Blue Ocean Strategy
 
Inovasyon disiplini - Peter F. Drucker
Inovasyon disiplini - Peter F. DruckerInovasyon disiplini - Peter F. Drucker
Inovasyon disiplini - Peter F. Drucker
 
Case Shouldice Hospital - Blueprint
Case Shouldice Hospital - BlueprintCase Shouldice Hospital - Blueprint
Case Shouldice Hospital - Blueprint
 
wk 4 models of innovation
wk 4 models of innovationwk 4 models of innovation
wk 4 models of innovation
 
Business Model Canvas Research Report
Business Model Canvas Research ReportBusiness Model Canvas Research Report
Business Model Canvas Research Report
 
Yenileşim (İnovasyon) Hunisini Geliştirmek
Yenileşim (İnovasyon) Hunisini GeliştirmekYenileşim (İnovasyon) Hunisini Geliştirmek
Yenileşim (İnovasyon) Hunisini Geliştirmek
 

Andere mochten auch

UCSF Life Sciences Week 2 Diagnostics
UCSF Life Sciences Week 2 DiagnosticsUCSF Life Sciences Week 2 Diagnostics
UCSF Life Sciences Week 2 DiagnosticsStanford University
 
UCSF Life Sciences Week 1 diagnostics
UCSF Life Sciences Week 1 diagnosticsUCSF Life Sciences Week 1 diagnostics
UCSF Life Sciences Week 1 diagnosticsStanford University
 
UCSF Life Sciences Week 2 Therapeutics: Customer Segments
UCSF Life Sciences Week 2 Therapeutics: Customer SegmentsUCSF Life Sciences Week 2 Therapeutics: Customer Segments
UCSF Life Sciences Week 2 Therapeutics: Customer SegmentsStanford University
 
UCSF Life Sciences Week 1 Therapeutics
UCSF Life Sciences Week 1 TherapeuticsUCSF Life Sciences Week 1 Therapeutics
UCSF Life Sciences Week 1 TherapeuticsStanford University
 
UCSF Life Sciences Week 2 digital health - Customer Sements
UCSF Life Sciences Week 2 digital health - Customer SementsUCSF Life Sciences Week 2 digital health - Customer Sements
UCSF Life Sciences Week 2 digital health - Customer SementsStanford University
 
UCSF Life Sciences Week 1 Devices
UCSF Life Sciences Week 1 DevicesUCSF Life Sciences Week 1 Devices
UCSF Life Sciences Week 1 DevicesStanford University
 
New 7 tam, sam, tad, som explained
New 7 tam, sam, tad, som explainedNew 7 tam, sam, tad, som explained
New 7 tam, sam, tad, som explainedZiya-B
 
Value proposition for medical devices
Value proposition for medical devicesValue proposition for medical devices
Value proposition for medical devicesNealda Yusof
 
Mira Medicine Final Presentation
Mira Medicine Final PresentationMira Medicine Final Presentation
Mira Medicine Final PresentationStanford University
 
Final Project - InterNexus - NN Group
Final Project - InterNexus - NN GroupFinal Project - InterNexus - NN Group
Final Project - InterNexus - NN GroupAron James Miszlivetz
 
Magnamosis inc final presentation 12 10
Magnamosis inc final presentation 12 10Magnamosis inc final presentation 12 10
Magnamosis inc final presentation 12 10Stanford University
 
What it Takes to Innovate in Large Organizations
What it Takes to Innovate in Large OrganizationsWhat it Takes to Innovate in Large Organizations
What it Takes to Innovate in Large OrganizationsStanford University
 
The Best Startup Investor Pitch Deck & How to Present to Angels & Venture Cap...
The Best Startup Investor Pitch Deck & How to Present to Angels & Venture Cap...The Best Startup Investor Pitch Deck & How to Present to Angels & Venture Cap...
The Best Startup Investor Pitch Deck & How to Present to Angels & Venture Cap...J. Skyler Fernandes
 
Foursquare's 1st Pitch Deck
Foursquare's 1st Pitch DeckFoursquare's 1st Pitch Deck
Foursquare's 1st Pitch DeckRami Al-Karmi
 
Linkedin Series B Pitch Deck
Linkedin Series B Pitch DeckLinkedin Series B Pitch Deck
Linkedin Series B Pitch DeckJoseph Hsieh
 
The slide deck we used to raise half a million dollars
The slide deck we used to raise half a million dollarsThe slide deck we used to raise half a million dollars
The slide deck we used to raise half a million dollarsBuffer
 

Andere mochten auch (17)

UCSF Life Sciences Week 2 Diagnostics
UCSF Life Sciences Week 2 DiagnosticsUCSF Life Sciences Week 2 Diagnostics
UCSF Life Sciences Week 2 Diagnostics
 
UCSF Life Sciences Week 1 diagnostics
UCSF Life Sciences Week 1 diagnosticsUCSF Life Sciences Week 1 diagnostics
UCSF Life Sciences Week 1 diagnostics
 
UCSF Life Sciences Week 2 Therapeutics: Customer Segments
UCSF Life Sciences Week 2 Therapeutics: Customer SegmentsUCSF Life Sciences Week 2 Therapeutics: Customer Segments
UCSF Life Sciences Week 2 Therapeutics: Customer Segments
 
UCSF Life Sciences Week 1 Therapeutics
UCSF Life Sciences Week 1 TherapeuticsUCSF Life Sciences Week 1 Therapeutics
UCSF Life Sciences Week 1 Therapeutics
 
UCSF Life Sciences Week 2 digital health - Customer Sements
UCSF Life Sciences Week 2 digital health - Customer SementsUCSF Life Sciences Week 2 digital health - Customer Sements
UCSF Life Sciences Week 2 digital health - Customer Sements
 
UCSF Life Sciences Week 1 Devices
UCSF Life Sciences Week 1 DevicesUCSF Life Sciences Week 1 Devices
UCSF Life Sciences Week 1 Devices
 
Knox final presentation
Knox final presentationKnox final presentation
Knox final presentation
 
New 7 tam, sam, tad, som explained
New 7 tam, sam, tad, som explainedNew 7 tam, sam, tad, som explained
New 7 tam, sam, tad, som explained
 
Value proposition for medical devices
Value proposition for medical devicesValue proposition for medical devices
Value proposition for medical devices
 
Mira Medicine Final Presentation
Mira Medicine Final PresentationMira Medicine Final Presentation
Mira Medicine Final Presentation
 
Final Project - InterNexus - NN Group
Final Project - InterNexus - NN GroupFinal Project - InterNexus - NN Group
Final Project - InterNexus - NN Group
 
Magnamosis inc final presentation 12 10
Magnamosis inc final presentation 12 10Magnamosis inc final presentation 12 10
Magnamosis inc final presentation 12 10
 
What it Takes to Innovate in Large Organizations
What it Takes to Innovate in Large OrganizationsWhat it Takes to Innovate in Large Organizations
What it Takes to Innovate in Large Organizations
 
The Best Startup Investor Pitch Deck & How to Present to Angels & Venture Cap...
The Best Startup Investor Pitch Deck & How to Present to Angels & Venture Cap...The Best Startup Investor Pitch Deck & How to Present to Angels & Venture Cap...
The Best Startup Investor Pitch Deck & How to Present to Angels & Venture Cap...
 
Foursquare's 1st Pitch Deck
Foursquare's 1st Pitch DeckFoursquare's 1st Pitch Deck
Foursquare's 1st Pitch Deck
 
Linkedin Series B Pitch Deck
Linkedin Series B Pitch DeckLinkedin Series B Pitch Deck
Linkedin Series B Pitch Deck
 
The slide deck we used to raise half a million dollars
The slide deck we used to raise half a million dollarsThe slide deck we used to raise half a million dollars
The slide deck we used to raise half a million dollars
 

Ähnlich wie UCSF Life Sciences Week 2 devices

Public Media Development and Marketing Conference 2013 - Atlanta, GA Healthca...
Public Media Development and Marketing Conference 2013 - Atlanta, GA Healthca...Public Media Development and Marketing Conference 2013 - Atlanta, GA Healthca...
Public Media Development and Marketing Conference 2013 - Atlanta, GA Healthca...TW Integrated Marketing
 
Health IT Summit San Francisco 2015 - Keynote Presentation "Tesla or Google? ...
Health IT Summit San Francisco 2015 - Keynote Presentation "Tesla or Google? ...Health IT Summit San Francisco 2015 - Keynote Presentation "Tesla or Google? ...
Health IT Summit San Francisco 2015 - Keynote Presentation "Tesla or Google? ...Health IT Conference – iHT2
 
Medical Quality Presentation 1998
Medical Quality Presentation 1998Medical Quality Presentation 1998
Medical Quality Presentation 1998rogerstrube
 
Anne Bracken Univ of South AL - aco rural health
Anne Bracken   Univ of South AL - aco rural healthAnne Bracken   Univ of South AL - aco rural health
Anne Bracken Univ of South AL - aco rural healthSamantha Haas
 
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...MedStatix, LLC
 
Maximizing efficiency and productivity in your ophthalmic practice
Maximizing efficiency and productivity in your ophthalmic practiceMaximizing efficiency and productivity in your ophthalmic practice
Maximizing efficiency and productivity in your ophthalmic practiceDr. Amani Masenya
 
Diagnostics Market Disruption HIDA final
Diagnostics Market Disruption HIDA finalDiagnostics Market Disruption HIDA final
Diagnostics Market Disruption HIDA finalHidee Cyd
 
Physician Referrals in a Digital Age - Brandi
Physician Referrals in a Digital Age - BrandiPhysician Referrals in a Digital Age - Brandi
Physician Referrals in a Digital Age - BrandiFast Track Marketing
 
What Veterinarians Can Learn From Physician Practice Models
What Veterinarians Can Learn From Physician Practice ModelsWhat Veterinarians Can Learn From Physician Practice Models
What Veterinarians Can Learn From Physician Practice Modelsmjmcgaunn
 
Patient /Medical Customer safety
Patient /Medical Customer safetyPatient /Medical Customer safety
Patient /Medical Customer safetygopalreddy narra
 
The Gemini Generic HIS
The Gemini Generic HISThe Gemini Generic HIS
The Gemini Generic HISThe Gemini
 
Anesthesia Business Consultants Communique Spring 2014 Edition
Anesthesia Business Consultants Communique Spring 2014 EditionAnesthesia Business Consultants Communique Spring 2014 Edition
Anesthesia Business Consultants Communique Spring 2014 EditionAnesthesia Business Consultants
 
ReSuture Pitch Deck Demo Day PDF
ReSuture Pitch Deck Demo Day PDF ReSuture Pitch Deck Demo Day PDF
ReSuture Pitch Deck Demo Day PDF Hannah Eherenfeldt
 
Embracing efficiency - Centricity Practice Solution Virginia Women's Center C...
Embracing efficiency - Centricity Practice Solution Virginia Women's Center C...Embracing efficiency - Centricity Practice Solution Virginia Women's Center C...
Embracing efficiency - Centricity Practice Solution Virginia Women's Center C...GE Healthcare - IT
 

Ähnlich wie UCSF Life Sciences Week 2 devices (20)

Service analysis
Service analysisService analysis
Service analysis
 
Public Media Development and Marketing Conference 2013 - Atlanta, GA Healthca...
Public Media Development and Marketing Conference 2013 - Atlanta, GA Healthca...Public Media Development and Marketing Conference 2013 - Atlanta, GA Healthca...
Public Media Development and Marketing Conference 2013 - Atlanta, GA Healthca...
 
Re-visioning Radiology
Re-visioning RadiologyRe-visioning Radiology
Re-visioning Radiology
 
Health IT Summit San Francisco 2015 - Keynote Presentation "Tesla or Google? ...
Health IT Summit San Francisco 2015 - Keynote Presentation "Tesla or Google? ...Health IT Summit San Francisco 2015 - Keynote Presentation "Tesla or Google? ...
Health IT Summit San Francisco 2015 - Keynote Presentation "Tesla or Google? ...
 
Medical Quality Presentation 1998
Medical Quality Presentation 1998Medical Quality Presentation 1998
Medical Quality Presentation 1998
 
Anne Bracken Univ of South AL - aco rural health
Anne Bracken   Univ of South AL - aco rural healthAnne Bracken   Univ of South AL - aco rural health
Anne Bracken Univ of South AL - aco rural health
 
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...
 
Advance Health Stanford 2016
Advance Health Stanford 2016Advance Health Stanford 2016
Advance Health Stanford 2016
 
AMI Solution Presentation
AMI Solution PresentationAMI Solution Presentation
AMI Solution Presentation
 
PCDD – A Roadmap
PCDD – A RoadmapPCDD – A Roadmap
PCDD – A Roadmap
 
PCDD – A Roadmap
PCDD – A RoadmapPCDD – A Roadmap
PCDD – A Roadmap
 
Maximizing efficiency and productivity in your ophthalmic practice
Maximizing efficiency and productivity in your ophthalmic practiceMaximizing efficiency and productivity in your ophthalmic practice
Maximizing efficiency and productivity in your ophthalmic practice
 
Diagnostics Market Disruption HIDA final
Diagnostics Market Disruption HIDA finalDiagnostics Market Disruption HIDA final
Diagnostics Market Disruption HIDA final
 
Physician Referrals in a Digital Age - Brandi
Physician Referrals in a Digital Age - BrandiPhysician Referrals in a Digital Age - Brandi
Physician Referrals in a Digital Age - Brandi
 
What Veterinarians Can Learn From Physician Practice Models
What Veterinarians Can Learn From Physician Practice ModelsWhat Veterinarians Can Learn From Physician Practice Models
What Veterinarians Can Learn From Physician Practice Models
 
Patient /Medical Customer safety
Patient /Medical Customer safetyPatient /Medical Customer safety
Patient /Medical Customer safety
 
The Gemini Generic HIS
The Gemini Generic HISThe Gemini Generic HIS
The Gemini Generic HIS
 
Anesthesia Business Consultants Communique Spring 2014 Edition
Anesthesia Business Consultants Communique Spring 2014 EditionAnesthesia Business Consultants Communique Spring 2014 Edition
Anesthesia Business Consultants Communique Spring 2014 Edition
 
ReSuture Pitch Deck Demo Day PDF
ReSuture Pitch Deck Demo Day PDF ReSuture Pitch Deck Demo Day PDF
ReSuture Pitch Deck Demo Day PDF
 
Embracing efficiency - Centricity Practice Solution Virginia Women's Center C...
Embracing efficiency - Centricity Practice Solution Virginia Women's Center C...Embracing efficiency - Centricity Practice Solution Virginia Women's Center C...
Embracing efficiency - Centricity Practice Solution Virginia Women's Center C...
 

Mehr von Stanford University

Team Networks - 2022 Technology, Innovation & Great Power Competition
Team Networks  - 2022 Technology, Innovation & Great Power CompetitionTeam Networks  - 2022 Technology, Innovation & Great Power Competition
Team Networks - 2022 Technology, Innovation & Great Power CompetitionStanford University
 
Team LiOn Batteries - 2022 Technology, Innovation & Great Power Competition
Team LiOn Batteries  - 2022 Technology, Innovation & Great Power CompetitionTeam LiOn Batteries  - 2022 Technology, Innovation & Great Power Competition
Team LiOn Batteries - 2022 Technology, Innovation & Great Power CompetitionStanford University
 
Team Quantum - 2022 Technology, Innovation & Great Power Competition
Team Quantum  - 2022 Technology, Innovation & Great Power CompetitionTeam Quantum  - 2022 Technology, Innovation & Great Power Competition
Team Quantum - 2022 Technology, Innovation & Great Power CompetitionStanford University
 
Team Disinformation - 2022 Technology, Innovation & Great Power Competition
Team Disinformation  - 2022 Technology, Innovation & Great Power CompetitionTeam Disinformation  - 2022 Technology, Innovation & Great Power Competition
Team Disinformation - 2022 Technology, Innovation & Great Power CompetitionStanford University
 
Team Wargames - 2022 Technology, Innovation & Great Power Competition
Team Wargames  - 2022 Technology, Innovation & Great Power CompetitionTeam Wargames  - 2022 Technology, Innovation & Great Power Competition
Team Wargames - 2022 Technology, Innovation & Great Power CompetitionStanford University
 
Team Acquistion - 2022 Technology, Innovation & Great Power Competition
Team Acquistion  - 2022 Technology, Innovation & Great Power Competition Team Acquistion  - 2022 Technology, Innovation & Great Power Competition
Team Acquistion - 2022 Technology, Innovation & Great Power Competition Stanford University
 
Team Climate Change - 2022 Technology, Innovation & Great Power Competition
Team Climate Change - 2022 Technology, Innovation & Great Power Competition Team Climate Change - 2022 Technology, Innovation & Great Power Competition
Team Climate Change - 2022 Technology, Innovation & Great Power Competition Stanford University
 
Altuna Engr245 2022 Lessons Learned
Altuna Engr245 2022 Lessons LearnedAltuna Engr245 2022 Lessons Learned
Altuna Engr245 2022 Lessons LearnedStanford University
 
Invisa Engr245 2022 Lessons Learned
Invisa Engr245 2022 Lessons LearnedInvisa Engr245 2022 Lessons Learned
Invisa Engr245 2022 Lessons LearnedStanford University
 
ānanda Engr245 2022 Lessons Learned
ānanda Engr245 2022 Lessons Learnedānanda Engr245 2022 Lessons Learned
ānanda Engr245 2022 Lessons LearnedStanford University
 
Gordian Knot Center Roundtable w/Depty SecDef
Gordian Knot Center Roundtable w/Depty SecDef Gordian Knot Center Roundtable w/Depty SecDef
Gordian Knot Center Roundtable w/Depty SecDef Stanford University
 
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Stanford University
 
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Stanford University
 
Team Catena - 2021 Technology, Innovation & Great Power Competition
Team Catena - 2021 Technology, Innovation & Great Power CompetitionTeam Catena - 2021 Technology, Innovation & Great Power Competition
Team Catena - 2021 Technology, Innovation & Great Power CompetitionStanford University
 
Team Apollo - 2021 Technology, Innovation & Great Power Competition
Team Apollo - 2021 Technology, Innovation & Great Power CompetitionTeam Apollo - 2021 Technology, Innovation & Great Power Competition
Team Apollo - 2021 Technology, Innovation & Great Power CompetitionStanford University
 
Team Drone - 2021 Technology, Innovation & Great Power Competition
Team Drone - 2021 Technology, Innovation & Great Power CompetitionTeam Drone - 2021 Technology, Innovation & Great Power Competition
Team Drone - 2021 Technology, Innovation & Great Power CompetitionStanford University
 
Team Short Circuit - 2021 Technology, Innovation & Great Power Competition
Team Short Circuit - 2021 Technology, Innovation & Great Power CompetitionTeam Short Circuit - 2021 Technology, Innovation & Great Power Competition
Team Short Circuit - 2021 Technology, Innovation & Great Power CompetitionStanford University
 
Team Aurora - 2021 Technology, Innovation & Great Power Competition
Team Aurora - 2021 Technology, Innovation & Great Power CompetitionTeam Aurora - 2021 Technology, Innovation & Great Power Competition
Team Aurora - 2021 Technology, Innovation & Great Power CompetitionStanford University
 
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...Stanford University
 
Lecture 8 - Technology, Innovation and Great Power Competition - Cyber
Lecture 8 - Technology, Innovation and Great Power Competition - CyberLecture 8 - Technology, Innovation and Great Power Competition - Cyber
Lecture 8 - Technology, Innovation and Great Power Competition - CyberStanford University
 

Mehr von Stanford University (20)

Team Networks - 2022 Technology, Innovation & Great Power Competition
Team Networks  - 2022 Technology, Innovation & Great Power CompetitionTeam Networks  - 2022 Technology, Innovation & Great Power Competition
Team Networks - 2022 Technology, Innovation & Great Power Competition
 
Team LiOn Batteries - 2022 Technology, Innovation & Great Power Competition
Team LiOn Batteries  - 2022 Technology, Innovation & Great Power CompetitionTeam LiOn Batteries  - 2022 Technology, Innovation & Great Power Competition
Team LiOn Batteries - 2022 Technology, Innovation & Great Power Competition
 
Team Quantum - 2022 Technology, Innovation & Great Power Competition
Team Quantum  - 2022 Technology, Innovation & Great Power CompetitionTeam Quantum  - 2022 Technology, Innovation & Great Power Competition
Team Quantum - 2022 Technology, Innovation & Great Power Competition
 
Team Disinformation - 2022 Technology, Innovation & Great Power Competition
Team Disinformation  - 2022 Technology, Innovation & Great Power CompetitionTeam Disinformation  - 2022 Technology, Innovation & Great Power Competition
Team Disinformation - 2022 Technology, Innovation & Great Power Competition
 
Team Wargames - 2022 Technology, Innovation & Great Power Competition
Team Wargames  - 2022 Technology, Innovation & Great Power CompetitionTeam Wargames  - 2022 Technology, Innovation & Great Power Competition
Team Wargames - 2022 Technology, Innovation & Great Power Competition
 
Team Acquistion - 2022 Technology, Innovation & Great Power Competition
Team Acquistion  - 2022 Technology, Innovation & Great Power Competition Team Acquistion  - 2022 Technology, Innovation & Great Power Competition
Team Acquistion - 2022 Technology, Innovation & Great Power Competition
 
Team Climate Change - 2022 Technology, Innovation & Great Power Competition
Team Climate Change - 2022 Technology, Innovation & Great Power Competition Team Climate Change - 2022 Technology, Innovation & Great Power Competition
Team Climate Change - 2022 Technology, Innovation & Great Power Competition
 
Altuna Engr245 2022 Lessons Learned
Altuna Engr245 2022 Lessons LearnedAltuna Engr245 2022 Lessons Learned
Altuna Engr245 2022 Lessons Learned
 
Invisa Engr245 2022 Lessons Learned
Invisa Engr245 2022 Lessons LearnedInvisa Engr245 2022 Lessons Learned
Invisa Engr245 2022 Lessons Learned
 
ānanda Engr245 2022 Lessons Learned
ānanda Engr245 2022 Lessons Learnedānanda Engr245 2022 Lessons Learned
ānanda Engr245 2022 Lessons Learned
 
Gordian Knot Center Roundtable w/Depty SecDef
Gordian Knot Center Roundtable w/Depty SecDef Gordian Knot Center Roundtable w/Depty SecDef
Gordian Knot Center Roundtable w/Depty SecDef
 
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
 
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
 
Team Catena - 2021 Technology, Innovation & Great Power Competition
Team Catena - 2021 Technology, Innovation & Great Power CompetitionTeam Catena - 2021 Technology, Innovation & Great Power Competition
Team Catena - 2021 Technology, Innovation & Great Power Competition
 
Team Apollo - 2021 Technology, Innovation & Great Power Competition
Team Apollo - 2021 Technology, Innovation & Great Power CompetitionTeam Apollo - 2021 Technology, Innovation & Great Power Competition
Team Apollo - 2021 Technology, Innovation & Great Power Competition
 
Team Drone - 2021 Technology, Innovation & Great Power Competition
Team Drone - 2021 Technology, Innovation & Great Power CompetitionTeam Drone - 2021 Technology, Innovation & Great Power Competition
Team Drone - 2021 Technology, Innovation & Great Power Competition
 
Team Short Circuit - 2021 Technology, Innovation & Great Power Competition
Team Short Circuit - 2021 Technology, Innovation & Great Power CompetitionTeam Short Circuit - 2021 Technology, Innovation & Great Power Competition
Team Short Circuit - 2021 Technology, Innovation & Great Power Competition
 
Team Aurora - 2021 Technology, Innovation & Great Power Competition
Team Aurora - 2021 Technology, Innovation & Great Power CompetitionTeam Aurora - 2021 Technology, Innovation & Great Power Competition
Team Aurora - 2021 Technology, Innovation & Great Power Competition
 
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
 
Lecture 8 - Technology, Innovation and Great Power Competition - Cyber
Lecture 8 - Technology, Innovation and Great Power Competition - CyberLecture 8 - Technology, Innovation and Great Power Competition - Cyber
Lecture 8 - Technology, Innovation and Great Power Competition - Cyber
 

Kürzlich hochgeladen

Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterMateoGardella
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.MateoGardella
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17Celine George
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingTeacherCyreneCayanan
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docxPoojaSen20
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfSanaAli374401
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDThiyagu K
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxVishalSingh1417
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxDenish Jangid
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxnegromaestrong
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 

Kürzlich hochgeladen (20)

Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 

UCSF Life Sciences Week 2 devices

  • 1. UCSF Lean Launchpad For Life Science and Healthcare Startups Medical Device Track Class 2 Customer Segments October 8, 2013 Allan May Chairman, Life Science Angels amay@lifescienceangels.com UCSF Lean Launchpad - Allan May ©
  • 2. MEDICAL DEVICE MARKETS ARE OFTEN - BUT NOT ALWAYS - MULTI-SIDED MARKETS  The patient is the beneficiary of the device or service and must receive a clinical benefit  The physician is the device user  The hospital or physician practice is the economic buyer  Medicare or private insurance payor is the ultimate influencer of what gets purchased  The FDA determines what can be legally sold  CMS determines what Medicare pays for UCSF Lean Launchpad - Allan May ©
  • 3. MEDICAL DEVICE CUSTOMER SEGMENTS IN A NUTSHELL  FOLLOW THE MONEY!!!  Understand whether the device is reimbursed   Being covered in the hospital DRG is NOT reimbursement, it is an expense Unless you are replacing a device currently being used within a DRG at a lesser cost  Determine who the payor is  Understand the funds flow process  Understand who gets paid  Same physician, or shifting specialties (and so some other physician will no longer get paid) UCSF Lean Launchpad - Allan May ©
  • 4. PHYSICIANS AS CUSTOMERS?  Physicians often decide what device to use   Depends on where the physician works; how she is paid Hospital-based physicians are influencers (at best)  The ability of physicians to influence hospital purchasing decisions is evaporating    Novare vs. Intuitive Surgical Same cost versus higher cost – Figure 8 Private practice physicians are purchasers  Actually multiple physician specialties often influence the course of therapy of a patient  EG, LCP Pacemaker - GP; cardiologist; interventional cardiologist; electrophysiologist  Physician turf battlers are common  E.g., cardiac surgeons versus interventional cardiologists UCSF Lean Launchpad - Allan May ©
  • 5. PATIENTS AS CUSTOMERS?   Competing trends are at work Patients are far better informed and increasingly request specific devices and procedures  Can impact where substantial data exists as to clinical outcomes and benefits     Prostate or breast cancer therapy choices But, the evidence requirement for new devices or procedures is daunting Physicians often recommend existing or standard devices and procedures until the adverse effects of new technology (and how to handle those effects) are well known Out-of-pocket or self-pay usually dooms device business models   Cosmetic versus therapeutic procedures Check out impact of reimbursement and market size – InvisiAlign http://provider.invisalign.com/Pages/pay.aspx UCSF Lean Launchpad - Allan May ©
  • 6. HOSPITALS AS CUSTOMERS?  Hospital purchases are increasingly governed by “New Technology Committees”, who’s purpose is to keep new technologies out of hospitals  Hospitals purchase devices that are reimbursed  Hospitals will only purchase devices that claim to lower costs where those cost benefits are proven by hard data  and often still require onsite trials to verify data generated elsewhere  Who is the Customer in the hospital?  What exactly is the purchasing process, and who all are involved in that process? UCSF Lean Launchpad - Allan May ©
  • 7. UNDERSTANDING CUSTOMERS REQUIRES UNDERSTANDING REIMBURSEMENT  Existing reimbursement code versus new code versus not reimbursed  Re-engineer your product or solution if possible to still achieve Product Market Fit while falling under an existing code  BTW, ditto for falling under 510k versus PMA (more later)  Understand the length of time it takes to get a new code and when you are able to effectively start  Understand who owns the patient and the physician referral process UCSF Lean Launchpad - Allan May ©
  • 8. INTERVIEWING PHYSICIANS  You need to view one or more target procedures to be effective in speaking with physicians  Take a prototype or mockup to hand/show them  Animations and CAD CAM is good but not good enough  Physicians are all difficult to interview effectively, but surgeons tend to be harder than non surgeons  Physicians are scientists and tend to answer exactly what is asked, not interpret what you meant to ask  Physicians often believe they are better than their peers and so don’t experience the complications or adverse events that others might  How do they perform the procedure? How would they do it better? What changes would they like? Why UCSF Lean Launchpad - Allan May ©
  • 9. PHYSICIAN – PATIENT GAINS  Same or better clinical outcomes in a less invasive setting  Invasive → less invasive → non-invasive   Often involves a reduction in expense Some procedures move out of hospital surgery to outpatient and then back  Opens up previously untreatable patients to therapy  Increases procedure speed (reduces complexity or time)  Count steps in the existing procedure versus yours  No Harm, No Foul solutions UCSF Lean Launchpad - Allan May ©
  • 10. PHYSICIAN – PATIENT PAINS  Reduces mortality  Reduces morbidity  Complications, adverse events  Increases durability of procedure   Balloon angioplasty → stents → Drug Eluting Stents But re-occurrence can generate additional physician revenue  Prevents losing patient to another specialty UCSF Lean Launchpad - Allan May ©
  • 11. MEDICAL DEVICE MARKET TYPES For Physicians and Hospitals  Existing   Better clinical outcomes; same physician If moves procedure to new physician (cardiac surgeon to interventional cardiologist), will provoke a turf war between supporters and saboteurs  Carotid stenting  Resegmented  Niche products aimed at specific patient populations have long been successful  New  If and when reimbursed, the solution is embraced  Clone  Often done regarding procedures; rare in devices due to IP UCSF Lean Launchpad - Allan May ©
  • 12. MEDICAL DEVICE COMPANIES AS ULTIMATE “CUSTOMERS”  Almost all innovation in medical devices resulted in acquisitions by major strategics  In-house R&D innovation is negligible  Is it still possible to build a major standalone medical device company?   Will there be another J&J, Medtronic, GE? Manufacturing is local; marketing, sales and customer support are global  What pain or gain do you provide to the acquiror?  Why can’t they just do the same thing without you? UCSF Lean Launchpad - Allan May ©
  • 13. MEDICAL DEVICE MARKET TYPES For Major Medical Device Companies  Existing   Better clinical outcomes; same physician If moves procedure to new physician (cardiac surgeon to interventional cardiologist), can fall outside of ability of major companies to leverage existing sales and marketing infrastructure   Resegmented     This is a good place for startups But major device companies are pretty good at this also The key is to spot holes in their IP New    Surgeons versus interventionalists The Holy Grail for startups Pioneering often requires startup to build its own sales and marketing channel to enable the major company to enter the market Clone  Probably not a place for startups to play UCSF Lean Launchpad - Allan May ©
  • 14. GAINS AND PAINS TO ACQUIRORS  Leverage existing corporate resources and customer call points  Gain entry with new widget to sell rest of line  Facilitate upselling  Increase market size  Add to sales and profits   Don’t cannibalize existing markets Eventually this will fail as reverse innovation becomes a reality  Create new markets  Increase share relative to competitors UCSF Lean Launchpad - Allan May ©
  • 15. UCSF Lean Launchpad For Life Science and Healthcare Startups Medical Device Track Class 2 Customer Segments October 8, 2013 Allan May Chairman, Life Science Angels amay@lifescienceangels.com UCSF Lean Launchpad - Allan May ©